JPRN-UMIN000048078已完成未知
ong-term impact of eculizumab on quality of life and patient-reported symptoms of Japanese GBS patients at 52 weeks post disease onset: an observational survey - ECU-GBS-LTO study
Alexion Pharma G.K.0 个研究点目标入组 99 人开始时间: 2022年6月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 99
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are unable to answer the study questionnaires and who do not have any next of kin or caregiver available to answer the study questionnaire on their behalf
研究者
相似试验
尚未招募
不适用
Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on EmicizumabHemophilia ANCT06104826Newark Beth Israel Medical Center50
Enrolling By Invitation
不适用
ong-term outcome of Quality of Life and Symptom Control after participation on the trial: Robotic versus Conventional laparoscopic fundoplication (ROLAF) TrialK21Gastro-oesophageal reflux diseaseDRKS00014690Klinik für Allgemein-, Viszeral- un Transplantationschirurgie Universität Heidelberg35
已完成
3 期
Escitalopram efficacy on quality of life and prevention of depression in breast cancer patient with mastectomyIRCT20180421039376N1Esfahan University of Medical Sciences75
招募中
不适用
Battery Powered 3D Printed Artificial hand made for use in persons with limb loss below the level of the elbow StudyCTRI/2021/02/031405Bionic Hope Private Limited
已完成
不适用
Quality Of Life Outcomes Following Treatment for Esophageal CancerEsophageal CancerNCT00598117Memorial Sloan Kettering Cancer Center409